SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-18-007642
Filing Date
2018-11-06
Accepted
2018-11-06 15:31:11
Documents
40
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_110518.htm 10-Q 196675
2 EXHIBIT 31.1 exh_311.htm EX-31.1 8501
3 EXHIBIT 31.2 exh_312.htm EX-31.2 8604
4 EXHIBIT 32 exh_32.htm EX-32 4302
  Complete submission text file 0001171843-18-007642.txt   2252377

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE caps-20180930.xml EX-101.INS 357852
6 XBRL SCHEMA FILE caps-20180930.xsd EX-101.SCH 27450
7 XBRL CALCULATION FILE caps-20180930_cal.xml EX-101.CAL 24402
8 XBRL DEFINITION FILE caps-20180930_def.xml EX-101.DEF 179914
9 XBRL LABEL FILE caps-20180930_lab.xml EX-101.LAB 184248
10 XBRL PRESENTATION FILE caps-20180930_pre.xml EX-101.PRE 196856
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21214 | Film No.: 181162796
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1